RPHM: Reneo Pharmaceuticals Forvard P/E multiplikatori

reneopharma.com (RPHM) grafik logotipi

Reneo Pharmaceuticals (RPHM) sovuq zanjir logistikasini diversifikatsiya qilish orqali noyob moddalarni yetkazib berishni optimallashtirishni maqsad qilgan. Kompaniyaning forward P/E koeffitsiyenti tarixi ushbu maqsad sari erishilgan progressni namoyish etadi va ushbu ko'rsatkich 0.00 ga yetdi. Biroq, o'tmishdagi muvaffaqiyatsizliklardan keyin obro'ni tiklash bilan bog'liq xatarlar hamda kelajakda noyob orfan dori vositalari uchun premium narx belgilash imkoniyatiga bog'liqlik ushbu yo'lni murakkablashtirmoqda.

reneopharma.com - RPHM Narxning kutilayotgan foydaga nisbati (davr: 04.07.2022 - 07.10.2024)

Reneo Pharmaceuticals, Inc. (RPHM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
reneopharma.com brendining mahsuloti

Reneo Pharmaceuticals (RPHM) kompaniyasining kam uchraydigan kasalliklarni davolash bo'yicha AQShning xavfsiz hududidagi ishlanmalari uzoq muddatli foyda o'sishi uchun asos yaratadi. Kompaniyaning forward P/E baholashi joriy aksiya narxining kutilayotgan daromadga nisbatini aks ettiradi, bu esa investorlarga kelajakdagi muvaffaqiyat uchun to'langan premiumni baholash yoki bozorning asossiz pessimizmi davrida kirish nuqtasini aniqlash imkonini beradi.

Reneo Pharmaceuticals raqobatchilari tahlili

Kelajakdagi narxning foydaga nisbati Vertex Pharmaceuticals Inc. (VRTX)|Kelajakdagi narxning foydaga nisbati ALNY (Alnylam Inc.)|Forvard P/E multiplikatori INSM (insmed.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati United Therapeutics Corporation (UTHR)|BMRN: Prognoz qilingan narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati BBIO|BGM: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cogent Bio (COGT)|XERS (Xeris Biopharma Holdings) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati KROS (Keros Therapeutics, Inc.)|Prognoz qilingan narxning foydaga nisbati ARCT (Arcturus Therapeutics Holdings Inc.)|ETON (Eton Pharmaceuticals Inc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Kamada KMDA|FULC (Fulcrum Tx) - Narxning kutilayotgan foydaga nisbati|Abeona Therapeutics Inc. - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori MREO (mereobiopharma.com)|Protalix BioTherapeutics, Inc. (PLX) - Kelajakdagi narxning foydaga nisbati|Pliant Rx (PLRX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Applied Therapeutics, Inc.|RNTX: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Gelteq Ltd (GELS)|Prognoz qilingan narxning foydaga nisbati Aytu BioPharma AYTU|Forvard P/E multiplikatori CMMB (Chemomab Therapeutics Ltd)|Forvard P/E multiplikatori SRx Health Solutions Inc. SRXH|PLRZ - Kelajakdagi narxning foydaga nisbati|AEZS - Forvard P/E multiplikatori|CYTH (Cyclo Therapeutics Inc.) - Prognoz qilingan narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati INZY|Kelajakdagi narxning foydaga nisbati COSCIENS Biopharma Inc